These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17695090)

  • 1. Entecavir in HIV/HBV coinfection: possible HIV activity and resistance risk.
    AIDS Clin Care; 2007 Apr; 19(4):32. PubMed ID: 17695090
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA notifications. FDA revises Baraclude labeling for HIV patients.
    AIDS Alert; 2007 Sep; 22(9):103-4. PubMed ID: 18415955
    [No Abstract]   [Full Text] [Related]  

  • 3. Common hepatitis B drug linked to HIV antiviral resistance.
    Future Microbiol; 2007 Apr; 2(2):104. PubMed ID: 17687802
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses.
    Soriano V; Sheldon J; García-Gasco P; Vispo E
    AIDS; 2007 Oct; 21(16):2253-4. PubMed ID: 18090058
    [No Abstract]   [Full Text] [Related]  

  • 5. Very few hepatitis trials recruiting.
    AIDS Patient Care STDS; 1998 Apr; 12(4):319-20. PubMed ID: 11361965
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA, Bristol-Myers Squibb issue warning on hepatitis B drug.
    AIDS Read; 2007 Oct; 17(10):478-510. PubMed ID: 17987701
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.
    Pessôa MG; Gazzard B; Huang AK; Brandão-Mello CE; Cassetti I; Mendes-Corrêa MC; Soriano V; Phiri P; Hall A; Brett-Smith H
    AIDS; 2008 Sep; 22(14):1779-87. PubMed ID: 18753861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatment of HIV/hepatitis B virus coinfection.
    Iser DM; Sasadeusz JJ
    J Gastroenterol Hepatol; 2008 May; 23(5):699-706. PubMed ID: 18410604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-hepatitis B virus coinfection: questions and answers.
    Valenti WM
    AIDS Read; 2005 May; 15(5):226-30. PubMed ID: 15900632
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV-1/hepatitis B coinfection.
    Benhamou Y
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):229-39. PubMed ID: 15918780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HIV-HBV-coinfection--diagnosis and therapy].
    Koch S; Göbels K; Oette M; Heintges T; Erhardt A; Häussinger D
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1873-7. PubMed ID: 16915550
    [No Abstract]   [Full Text] [Related]  

  • 12. [Entecavir - options and obstacles of an effective treatment for chronic hepatitis B].
    Cornberg M; Manns MP
    Dtsch Med Wochenschr; 2010 Jan; 135(1-2):32-7. PubMed ID: 20024882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HIV and hepatitis coinfection].
    Ingiliz P; Rockstroh JK
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S216-8. PubMed ID: 16435714
    [No Abstract]   [Full Text] [Related]  

  • 14. Special considerations and treatment of patients with HBV-HIV coinfection.
    Dieterich DT
    Antivir Ther; 2007; 12 Suppl 3():H43-51. PubMed ID: 18284182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral hepatitis and HIV coinfection.
    Sulkowski MS
    J Hepatol; 2008 Feb; 48(2):353-67. PubMed ID: 18155314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HBV drug entecavir - effects on HIV-1 replication and resistance.
    McMahon MA; Jilek BL; Brennan TP; Shen L; Zhou Y; Wind-Rotolo M; Xing S; Bhat S; Hale B; Hegarty R; Chong CR; Liu JO; Siliciano RF; Thio CL
    N Engl J Med; 2007 Jun; 356(25):2614-21. PubMed ID: 17582071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response.
    Baldick CJ; Eggers BJ; Fang J; Levine SM; Pokornowski KA; Rose RE; Yu CF; Tenney DJ; Colonno RJ
    J Hepatol; 2008 Jun; 48(6):895-902. PubMed ID: 18362040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New advances in the treatment of chronic hepatitis B: position of entecavir].
    Olaso V
    Rev Esp Quimioter; 2007 Sep; 20(3):259-60. PubMed ID: 18080023
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and management of hepatitis B virus and HIV coinfection.
    Peters MG
    Top HIV Med; 2007; 15(5):163-6. PubMed ID: 18073452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of an effect of human immunodeficiency virus coinfection on the pharmacokinetics of entecavir in hepatitis B virus-infected patients.
    Zhu M; Bifano M; Xu X; Wang Y; LaCreta F; Grasela D; Pfister M
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2836-41. PubMed ID: 18391039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.